US Stock Market Movement: Genmab Surges on October 5 Due to AbbVie Collaboration, EPKINLY Phase III Results, and Rina-S
Bitget异动解读2026/10/05 18:55Genmab Surges on October 5th: Analysis
Keywords: AbbVie collaboration, EPKINLY Phase III, Rina-S
1. On October 6th, Genmab and AbbVie announced that the Phase III trial of EPKINLY combined with R-CHOP for the treatment of newly diagnosed diffuse large B-cell lymphoma showed a statistically significant improvement in progression-free survival, with a 51% reduction in the risk of disease progression or death.
2. On October 3rd, Genmab released data from the RAINFOL-01 trial of Rina-S for the treatment of platinum-resistant ovarian cancer: among 109 patients, the confirmed objective response rate was 45.9%, including 5 complete responses, with a median duration of response of 12.1 months and median progression-free survival of 9.5 months. Antitumor activity was observed regardless of FRα expression level and prior treatment with mirvetuximab.
(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of America and others launch $60 billion financing to support Anthropic leasing Google AI chips
According to the Financial Times, Bank of America, Citigroup, and Morgan Stanley have begun distributing a total debt financing package of $60 billion to other banks, to support Anthropic’s leasing of Google (GOOG.US) AI chips in what is the largest chip financing deal to date. Of this amount, approximately $42 billion consists of senior secured loans backed by Broadcom (AVGO.US), with syndication launching on Monday; an additional $18 billion, a tranche of subordinated debt without Broadcom’s backing, is expected to be launched later, with Blackstone committed to providing about $9 billion of the funding. The funds raised will support Anthropic’s chip orders for 2027, with lease payments beginning after chip delivery. Broadcom may also receive up to $42 billion in convertible notes from Anthropic as payment for related leasing costs. This $60 billion financing is being seen as a key test of market demand for AI-related debt.
Wall Street banks launch $60 billion chip deal for Broadcom and Anthropic
According to the Financial Times, Wall Street banks have launched a record-breaking $60 billion chip deal involving Broadcom and Anthropic.
Nasdaq rises 1.05%, Nvidia surges 2.12% leading active stocks
The Dow Jones closed up 0.18%, the Nasdaq rose 1.05%, and the S&P 500 gained 0.66%. Among the stocks with the highest trading volumes, Nvidia rose 2.12%, SpaceX surged 7.63%, Micron Technology fell 1.02%, and Tesla increased 2.2%.
Fitch says North American oil hedging currently faces book losses, natural gas traders lock in prices for 2028
Fitch Ratings has published a related assessment showing that oil hedging operations in North America have currently resulted in paper losses, while natural gas producers are moving to lock in favorable prices for 2028. It is understood that hedging activities by energy companies are primarily intended to counter commodity price fluctuations and stabilize operating cash flows. The recent paper losses in oil hedging are directly linked to the volatility in international oil prices. Meanwhile, natural gas producers' decisions to secure advantageous prices years in advance reflect the industry’s clear expectations regarding future supply and demand dynamics and price trends for natural gas. This early positioning aims to safeguard future profit margins and mitigate the operational uncertainties that potential market price fluctuations may bring.
Crypto prices
More
